DNA flow-cytometric analysis in colorectal cancer: A comparison of metastasizing and non-metastasizing tumours

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 4, 1996, Pages 319-324

  Yang, J L ^a   Crowe, P J ^a   Ow, K T ^a   Ham, J M ^a   Crouch, R L ^a   Russell, P J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

colorectal cancer; DNA cytometry; hepatic metastases

Indexed keywords

ARTICLE; CELL CYCLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; LIVER METASTASIS; MAJOR CLINICAL STUDY; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029876701     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb01378.x     Document Type: Article

References (34)

1. 1 Silverberg E., Lubera J. Cancer statistics 1987. Cancer J. Clin. 1987 ; 37: 2–19.
2. 2 Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg. 1954 ; 139: 846–52.
3. 3 Roseman DL, Straus AK. Staging of carcinoma of the colon and rectum. Surg. Gynecol. Obstet. 1980 ; 151: 93–5.
4. 4 Blenkinsopp WK, Stewart‐Brown S., Blesovsky L., Kearney G., Fielding LP. Histopathology reporting in large bowel cancer. J. Clin. Pathol. 1981 ; 34: 509–13.
5. 5 Coon JS. Prognostic significance of DNA content abnormalities and measurements of cell proliferation. In: Wanebo HJ, ed. Colorectal Cancer. St Louis: Mosby, 1993 ; 75–85.
6. 6 Enblad P., Glimelius B., Bengtsson A., Ponten J., Pahlman L. The prognostic significance of DNA content in carcinoma of the rectum and rectosigmoid. Acta Chir. Scand. 1987 ; 153: 453–8.
7. 7 Yamagucbi A., Ishida T., Takegawa S. et al. Flow‐cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis. Oncology 1990 ; 47: 478–82.
8. 8 Melamed MR, Enker WE, Banner P., Janov AJ, Kessler G., Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three‐year follow‐up. Dis. Colon Rectum 1986 ; 29: 184–6.
9. 9 Finan PJ, Quirke P., Bird CC et al. Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer ? Br. J. Cancer 1986 ; 54: 327–30.
10. 10 Hedley DW, Friedlander ML, Taylor IW, Rugg GA, Musgrove EA. Method for analysis of cellular DNA content of paraffin‐embedded pathological material using flow cytometry. J. Histochem. Cytochem. 1983 ; 31: 1333–5.
11. 11 Hadjissotiriou GG, Green DK, Chisholm GD et al. Bladder cancer flow cytometry profiles in relation to histological grade and stage. Br. J. Urol. 1987 ; 60: 239–47.
12. 12 Balslev I., Christensen IJ, Mouridsen HT et al. Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancer. Int. J. Cancer 1994 ; 56: 16–25.
13. 13 Witzig TE, Loprinzi CL, Gonchoroff NL et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal carcinoma. Cancer 1991 ; 68: 879–88.
14. 14 Albe X., Vassilakos P., Helfer‐Guarnori K. et al. Independent prognostic value of ploidy in colorectal cancer. Cancer 1990 ; 66: 1168–75.
15. 15 Forsslund G., Cedermark B., Ohman U., Erhardt K., Zetterberg A., Auer G. The significance of DNA distribution pattern in rectal carcinoma. Dis. Colon Rectum 1984 ; 27: 579–84.
16. 16 Wolley RC, Schreiber K., Koss LG, Karas M., Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J. Natl Cancer Inst. 1982 ; 69: 15–22.
17. 17 Kokal W., Sheibani K., Terz J., Harada JR. Tumour DNA content in the prognosis of colorectal carcinoma. JAMA 1986 ; 255: 3123–7.
18. 18 Emdin SO, Stenling R., Roos G. Prognostic value of DNA content in colorectal carcinoma: a flow cytometric study with some methodologic aspects. Cancer 1987 ; 60: 1282–7.
19. 19 Goh HS, Jass JR, Atkin WS, Cuzick J., Northorer JM. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis. Int. J. Colorectal Dis. 1987 ; 2: 17–21.
20. 20 Quirke P., Dixon MF, Clayden AD et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J. Pathol. 1987 ; 151: 285–91.
21. 21 Schutte B., Reynders MJ, Wiggers T. et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res. 1987 ; 47: 5494–6.
22. 22 Scott NA, Rainwater LM, Wieand HS et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis. Colon Rectum 1987 ; 30: 513–20.
23. 23 Jones DJ, Moore M., Schofield PF. Refining the prognostic significance of DNA ploidy status in colorectal cancer: A prospective flow cytometric study. Int. J. Cancer 1988 ; 41: 206–10.
24. 24 Wiggers T., Arends JW, Schutte B., Volovics L., Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel carcinoma. Cancer 1988 ; 61: 386–95.
25. 25 Kokal WA, Gardine RL, Shiebani K. et al. Tumour DNA content in resectable primary colorectal carcinoma. Ann. Surg. 1989 ; 209: 188–93.
26. 26 Rowley S., Newbold KM, Gearty J., Keighley MR, Donovan IA, Neoptolemas JP. Comparison of deoxyribonucleic acid ploidy and nuclear p62 c‐myc oncogene in the prognosis of colorectal cancer. World J. Surg. 1990 ; 14: 545–50.
27. 27 Armitage NCM, Ballantyne KC, Sheffield JP, Clarke P., Evans DF, Hardcastle JD. A prospective evaluation of the effect of tumour cell DNA content on recurrence in colorectal cancer. Cancer 1991 ; 67: 2599–604.
28. 28 Giaretti W., Danova M., Gerdo E. et al. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991 ; 67: 1921–7.
29. 29 Bauer KD, Lincoln ST, Vera‐Roman JM et al. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab. Invest. 1987 ; 57: 329–35.
30. 30 Fisher ER, Siderits RH, Sass R., Fisher B. Value of assessment of ploidy in rectal cancers. Arch. Pathol. Lab. Med. 1989 ; 113: 525–8.
31. 31 Jass JR, Mukawa K., Goh HS, Love SB, Capellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J. Clin. Pathol. 1989 ; 42: 254–9.
32. 32 Scott NA, Beart Jr RW, Weiland LH, Cha SS, Lieber MM. Carcinoma of the anal canal and flow cytometric DNA analysis. Br. J. Cancer 1989 ; 60: 56–8.
33. 33 Enker WE, Kimmel M., Cibas ES, Cranor ML, Melamed MR. DNA/RNA content and proliferative fractions of colorectal carcinomas: a 5–year prospective study relating flow cytometry to survival. J. Natl Cancer Inst. 1991 ; 83: 701–7.
34. 34 Harlow SP, Eriksen BL, Poggensee L. et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler‐Coller Dukes' stage C colonic adenocarcinomas. Cancer Res. 1991 ; 51: 2403–9.